Manufacturing Planning Sample Clauses

Manufacturing Planning. The Contractor shall update their Manufacturing Plan to include VLS LCU being produced by the Contractor under this contract. The Contractor shall develop manufacturing and test procedures. The Contractor shall identify key production processes and shall establish process capability and process control requirements for each. The Contractor shall submit Progress, Status, and Management reports to cover progress, schedule performance, technical and quality problems and other issues as may be appropriate to facilitate program management by the Government in accordance with CDRL A005.
Sample 1Sample 2Sample 3See All (9)
AutoNDA by SimpleDocs
Manufacturing Planning. The Contractor shall update their Manufacturing Plan to include VLS UCEU and associated cables being produced by the Contractor under this contract. The Contractor shall develop manufacturing and test procedures. The Contractor shall identify key production processes and shall establish process capability and process control requirements for each. The Contractor shall submit Progress, Status, and Management reports to cover progress, schedule performance, technical and quality problems and other issues as may be appropriate to facilitate program management by the Government in accordance with CDRL A005.
Sample 1Sample 2Sample 3See All (6)
Manufacturing Planning. The Contractor shall update their Manufacturing Plan to include VLS MTP being produced by the Contractor under this contract. The Contractor shall develop manufacturing and test procedures. The Contractor shall identify key production processes and shall establish process capability and process control requirements for each. The Contractor shall submit Progress, Status, and Management reports to cover progress, schedule performance, technical and quality problems and other issues as may be appropriate to facilitate program management by the Government in accordance with CDRL A005.
Sample 1Sample 2
Manufacturing Planning. Demand Chain Voyager . Supply Chain Voyager EXHIBIT D --------- STATE OF GEORGIA COUNTY OF XXXXXX XXXX OF SALE ------------ KNOW ALL MEN BY THESE PRESENTS: FOR AND IN CONSIDERATION of Ten and No/100 Dollars ($10.00) and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the undersigned AMERICAN SOFTWARE, INC., a Georgia corporation, AMERICAN SOFTWARE USA, INC., a Georgia corporation, AMERICAN SOFTWARE (UK) LTD., an entity existing under the laws of the United Kingdom, AMERICAN SOFTWARE FRANCE S.A., an entity existing under the laws of France, AMERICAN SOFTWARE ASIA PACIFIC PTE. LTD., an entity existing under the laws of Singapore, AMERICAN SOFTWARE (JAPAN) KK, an entity existing under the laws of Japan, and AMERICAN SOFTWARE (AUSTRALIA) PTY. LTD., an entity existing under the laws of Australia (collectively, "Sellers"), hereby do sell, transfer, assign, bargain, convey and deliver unto LOGILITY, INC., a Georgia corporation ("Buyer"), its successors and assigns, all of Sellers' right, title and interest in and to all of the "Logility Assets", as such term is defined in that certain Subsidiary Formation Agreement between Sellers and Buyer, dated January 23, 1997 (the "Subsidiary Formation Agreement"), the terms and provisions of which are incorporated herein by reference. Sellers, on behalf of their successors, successors-in-title and assigns, represent, warrant and agree that they are the true, lawful and sole owners of the Logility Assets hereby sold, transferred, assigned, bargained, conveyed and delivered, subject to no security interests, liens, restrictions, encumbrances, leases, easements or claims or rights of any third parties whatsoever; that they have the full, complete and lawful right, power and authority to execute this Xxxx of Sale and to so contribute, transfer, assign, bargain, convey and deliver the Logility Assets; that the right, title and interest in the Logility Assets hereby sold, transferred, assigned, bargained, conveyed and delivered constitute good and marketable title to the Logility Assets, free and clear of all security interests, liens, restrictions, encumbrances, leases, easements and claims or rights of third parties of every kind and nature whatsoever; and that no other person, firm, corporation or entity of any kind has any claim to or interest in the Logility Assets. TO HAVE AND TO HOLD the Logility Assets unto the Buyer, its successors, successors-in-title and assigns ...
Sample 1Sample 2
Manufacturing Planning. 33 6.1.4. BI'S OPTION FOR MANUFACTURING LICENSE .... 33 6.2. MARKETING AND DISTRIBUTION RIGHTS AND OBLIGATIONS . 33 6.2.1. BI MARKETING RIGHT AND DILIGENCE OBLIGATIONS .............................. 33 6.2.2. TRANSCEND CO-PROMOTION OPTION ............ 35
Sample 1Sample 2
Manufacturing Planning. In order to ensure either an orderly transition of manufacturing responsibility from Transcend to BI pursuant to Section 6.1.4 or the continuation of Transcend's manufacturing responsibility, the Parties agree to engage in joint long-term manufacturing planning.
Sample 1Sample 2
Manufacturing Planning. The Contractor shall update their Manufacturing Plan to include VLS cables being produced by the Contractor under this contract. The Contractor shall develop manufacturing and test procedures. The Contractor shall identify key production processes and shall establish process capability and process control requirements for each. The Contractor shall submit Progress, Status, and Management reports to cover progress, schedule performance, technical and quality problems and other issues as may be appropriate to facilitate program management by the Government in accordance with CDRL A005.
Sample 1
AutoNDA by SimpleDocs

Related to Manufacturing Planning

  • Manufacturing and Marketing Rights The Company has not granted rights to manufacture, produce, assemble, license, market, or sell its products to any other person and is not bound by any agreement that affects the Company's exclusive right to develop, manufacture, assemble, distribute, market, or sell its products.

  • Manufacturing (a) The Supplier shall without limitation be responsible, at no additional cost to the Purchaser, for: sourcing and procuring all raw materials for the Products; obtaining all necessary approvals, permits and licenses for the manufacturing of the Products; providing sufficient qualified staff and workers to perform the obligations under this Purchase Agreement; implementing and maintaining effective inventory and production control procedures with respect to the Products; and handling other matters as reasonably requested by the Purchaser from time to time.

  • Manufacturing Technology Transfer With respect to each Technology Transfer Product, upon AbbVie’s written request after the Inclusion Date for the Included Target to which such Technology Transfer Product is Directed, Morphic shall effect a full transfer to AbbVie or its designee (which designee may be an Affiliate or a Third Party manufacturer) of all Morphic Know-How and Joint Know-How relating to the then-current process for the Manufacture of such Technology Transfer Product (the “Manufacturing Process”) and to implement the Manufacturing Process at facilities designated by AbbVie (such transfer and implementation, as more fully described in this Section 5.3, the “Manufacturing Technology Transfer”). To assist with the Manufacturing Technology Transfer, Morphic will make its personnel reasonably available to AbbVie during normal business hours for up to [***] FTE hours with respect to each Included Target (in each case, free of charge to AbbVie) to transfer and implement the Manufacturing Process under this Section 5.3. Thereafter, if requested by AbbVie, Morphic shall continue to perform such obligations; provided, that AbbVie will reimburse Morphic for its full-time equivalent (FTE) costs (for clarity, in excess of [***] FTE hours) and any reasonable and verifiable out-of-pocket costs incurred in providing such assistance. CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED.

  • Manufacturing Services Jabil will manufacture the Product in accordance with the Specifications and any applicable Build Schedules. Jabil will reply to each proposed Build Schedule that is submitted in accordance with the terms of this Agreement by notifying Company of its acceptance or rejection within three (3) business days of receipt of any proposed Build Schedule. In the event of Jabil’s rejection of a proposed Build Schedule, Jabil’s notice of rejection will specify the basis for such rejection. When requested by Company, and subject to appropriate fee and cost adjustments, Jabil will provide Additional Services for existing or future Product manufactured by Jabil. Company shall be solely responsible for the sufficiency and adequacy of the Specifications [***].

  • Clinical Development Licensee will have sole responsibility for and sole decision making over the clinical development of any Product arising from the Research Program in the Field. Notwithstanding the foregoing, if Licensee wishes to conduct clinical development of a Development Candidate at Penn and Penn has the clinical expertise, interest and ability to run such a trial as assessed at Penn’s sole discretion, such a study will be conducted under a separate Clinical Trial Agreement to be negotiated by the Parties prior to initiation of such study. Such separate clinical trial agreement will include a detailed clinical development plan, including costs and time lines for conducting the Clinical Trial.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Marketing Plan The MCP shall submit an annual marketing plan to ODM that includes all planned activities for promoting membership in or increasing awareness of the MCP. The marketing plan submission shall include an attestation by the MCP that the plan is accurate is not intended to mislead, confuse or defraud the eligible individuals or ODM.

  • Joint Manufacturing Committee In accordance with Section 2.5(c)(iv), the Parties shall promptly establish and convene a joint Manufacturing Committee (the “JMC”) for the overall coordination and oversight of the Manufacturing of clinical and commercial supplies of the Product under this Agreement as provided in the Manufacturing Plan (including the Manufacture of API, Drug Product and Finished Product). The JMC shall consist of representatives of each Party, and shall operate by procedures, as set forth in Section 2.5. The role of the JMC shall be:

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Contract Area, including its abandonment.

  • Commercialization Activities Within North America, the Parties will use Commercially Reasonable Efforts to Commercialize Licensed Products in the Field. In addition, within North America and subject to Section 2.7.6, the Parties will use Commercially Reasonable Efforts to conduct the Commercialization activities assigned to them pursuant to the Commercialization Plan/Budget, including the performance of detailing in accordance therewith. In conducting the Commercialization activities, the Parties will comply with all Applicable Laws, applicable industry professional standards and compliance policies of Celgene which have been previously furnished to Acceleron, as the same may be updated from time to time and provided to Acceleron. Neither Party shall make any claims or statements with respect to the Licensed Products that are not strictly consistent with the product labeling and the sales and marketing materials approved for use pursuant to the Commercialization Plan/Budget.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!